Matches in Nanopublications for { ?s ?p "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP333730.RASLdW8SLRbPyinZS2tbWhTZQWGYPo6C6hUyMo9nEU6Dw130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333730.RASLdW8SLRbPyinZS2tbWhTZQWGYPo6C6hUyMo9nEU6Dw130_provenance.
- NP333912.RAYvZN2C5jQmwQiG78z7f2VON4VxgLjlQcoADFQC8YSFM130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333912.RAYvZN2C5jQmwQiG78z7f2VON4VxgLjlQcoADFQC8YSFM130_provenance.
- NP333833.RABJfbgJRGX1IQ5xkkMDRn8K73XkJfQ2MLt4LT5h3bFeM130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333833.RABJfbgJRGX1IQ5xkkMDRn8K73XkJfQ2MLt4LT5h3bFeM130_provenance.
- NP1015358.RAUaXXIaK7nXkAfQbbcCOGQK-1CeHbQaLSD9DGcRQQ-3E130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015358.RAUaXXIaK7nXkAfQbbcCOGQK-1CeHbQaLSD9DGcRQQ-3E130_provenance.
- NP1015359.RAByhQgTZ7Nd4VZSSeTVwO6cL32WMFb9NrdjoqwOcbkGQ130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015359.RAByhQgTZ7Nd4VZSSeTVwO6cL32WMFb9NrdjoqwOcbkGQ130_provenance.
- NP1015350.RAk3mwB6GxCJDQf6HYiKC_BfmK47k_oNMaHfy0L4hLJtg130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015350.RAk3mwB6GxCJDQf6HYiKC_BfmK47k_oNMaHfy0L4hLJtg130_provenance.
- NP333671.RA-zHHKVHiAXSugprms657BzAxa6QQoawcTp5FRdJvzAs130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333671.RA-zHHKVHiAXSugprms657BzAxa6QQoawcTp5FRdJvzAs130_provenance.
- NP1015357.RA-8hFAenkUcxRco9tPkR8t2cNNgjtouJhb8m1l9E1y-U130_assertion description "[CST6 promoter methylation in cfDNA, should be prospectively validated as a novel plasma tumor biomarker for breast cancer in a large cohort of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015357.RA-8hFAenkUcxRco9tPkR8t2cNNgjtouJhb8m1l9E1y-U130_provenance.